News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
769,319 Results
Type
Article (59188)
Company Profile (338)
Press Release (709793)
Section
Business (218703)
Career Advice (2876)
Deals (37619)
Drug Delivery (121)
Drug Development (86660)
Employer Resources (186)
FDA (17361)
Job Trends (16226)
News (371583)
Policy (36565)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (5)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (7)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2948)
Academic (2)
Accelerated approval (4)
Adcomms (27)
Allergies (87)
Alliances (53610)
ALS (92)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (132)
Approvals (17334)
Artificial intelligence (268)
Autoimmune disease (19)
Automation (14)
Bankruptcy (389)
Best Places to Work (12463)
BIOSECURE Act (19)
Biosimilars (114)
Biotechnology (228)
Bladder cancer (63)
Brain cancer (28)
Breast cancer (270)
Cancer (2137)
Cardiovascular disease (185)
Career advice (2413)
Career pathing (32)
CAR-T (152)
Cell therapy (428)
Cervical cancer (20)
Clinical research (69962)
Collaboration (826)
Compensation (474)
Complete response letters (27)
COVID-19 (2830)
CRISPR (42)
C-suite (231)
Cystic fibrosis (104)
Data (2028)
Decentralized trials (2)
Denatured (28)
Depression (49)
Diabetes (268)
Diagnostics (6849)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (93)
Earnings (89442)
Editorial (40)
Employer branding (23)
Employer resources (159)
Events (123718)
Executive appointments (689)
FDA (18531)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (742)
Gene editing (110)
Generative AI (28)
Gene therapy (315)
GLP-1 (794)
Government (5051)
Grass and pollen (5)
Guidances (49)
Healthcare (20616)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (126)
Indications (27)
Infectious disease (2976)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (89)
Interviews (556)
IPO (17136)
IRA (50)
Job creations (4223)
Job search strategy (1996)
Kidney cancer (10)
Labor market (34)
Layoffs (511)
Leadership (20)
Legal (8990)
Liver cancer (76)
Lung cancer (314)
Lymphoma (135)
Machine learning (4)
Management (64)
Manufacturing (289)
MASH (68)
Medical device (14250)
Medtech (14255)
Mergers & acquisitions (20965)
Metabolic disorders (702)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (98)
Neuropsychiatric disorders (29)
Neuroscience (2003)
NextGen: Class of 2025 (7327)
Non-profit (5009)
Northern California (2510)
Now hiring (37)
Obesity (380)
Opinion (255)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (79)
Parkinson's disease (146)
Partnered (20)
Patents (216)
Patient recruitment (100)
Peanut (51)
People (62512)
Pharmaceutical (79)
Pharmacy benefit managers (20)
Phase I (21722)
Phase II (30616)
Phase III (22918)
Pipeline (1095)
Podcasts (86)
Policy (135)
Postmarket research (3052)
Preclinical (9318)
Press Release (72)
Prostate cancer (98)
Psychedelics (38)
Radiopharmaceuticals (266)
Rare diseases (397)
Real estate (6542)
Recruiting (72)
Regulatory (24657)
Reports (47)
Research institute (2603)
Resumes & cover letters (454)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (74)
Series A (132)
Series B (84)
Service/supplier (15)
Sickle cell disease (57)
Southern California (2184)
Special edition (17)
Spinal muscular atrophy (160)
Sponsored (31)
Startups (3960)
State (2)
Stomach cancer (16)
Supply chain (66)
Tariffs (14)
The Weekly (56)
United States (22352)
Vaccines (754)
Venture capitalists (39)
Webinars (13)
Weight loss (269)
Women's health (37)
Worklife (18)
Date
Last 7 days (696)
Last 30 days (2556)
Last 365 days (35109)
2025 (8810)
2024 (37150)
2023 (42116)
2022 (53384)
2021 (58184)
2020 (57158)
2019 (50602)
2018 (38427)
2017 (35053)
2016 (35386)
2015 (41501)
2014 (35531)
2013 (30998)
2012 (32988)
2011 (33548)
2010 (31994)
Location
Africa (981)
Alabama (53)
Alaska (7)
Arizona (247)
Arkansas (14)
Asia (43640)
Australia (7891)
California (5758)
Canada (1911)
China (501)
Colorado (258)
Connecticut (277)
Delaware (135)
Europe (97449)
Florida (843)
Georgia (209)
Hawaii (1)
Idaho (63)
Illinois (555)
India (25)
Indiana (309)
Iowa (9)
Japan (146)
Kansas (104)
Kentucky (25)
Louisiana (11)
Maine (69)
Maryland (889)
Massachusetts (4411)
Michigan (232)
Minnesota (394)
Mississippi (2)
Missouri (86)
Montana (30)
Nebraska (25)
Nevada (57)
New Hampshire (69)
New Jersey (1657)
New Mexico (31)
New York (1659)
North Carolina (1031)
North Dakota (7)
Northern California (2510)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1290)
Puerto Rico (10)
Rhode Island (29)
South America (1351)
South Carolina (19)
South Dakota (1)
Southern California (2184)
Tennessee (98)
Texas (860)
Utah (172)
Virginia (141)
Washington D.C. (64)
Washington State (542)
West Virginia (3)
Wisconsin (59)
769,319 Results for "trividia health formerly known as nipro diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Biotech Beach
Allez Health Announces $60 Million Capital Raise
Allez Health Inc., formerly known as Zense-Life Inc., an emerging biosensor venture founded by proven experts in the continuous glucose monitoring space, announced a $60 million Series A+ financing.
May 22, 2024
·
2 min read
Press Releases
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health
February 20, 2025
·
4 min read
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Deals
Quest Diagnostics to Acquire Select Lab Assets from Allina Health
Quest Diagnostics and Allina Health announced a definitive agreement for Quest to acquire select laboratory assets from Allina Health, with the goal to improve access to and the affordability of innovative laboratory services across Minnesota and western Wisconsin.
June 26, 2024
·
2 min read
Press Releases
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 6, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Astrana Health, Inc. Schedules 2024 Fourth Quarter and Full Year Financial Results Release and Conference Call
February 17, 2025
·
2 min read
Press Releases
Ferring Inc. Receives Health Canada Approval for REBYOTA® (fecal microbiota, live)
March 7, 2025
·
9 min read
1 of 76,932
Next
